Janu Putra Sejahtera Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Janu Putra Sejahtera Tbk. trades at Rp354 (market cap 1.4T, 42.11M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Janu Putra Sejahtera Tbk. is far larger — about 8.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Janu Putra Sejahtera Tbk. is more actively traded (42.11M versus 214.9K). Which is the better fit depends on your goals.
| AYAM | OBAT | |
|---|---|---|
Market Cap | 1.4T | 164.65B |
Volume | 42.11M | 214.9K |
Lot | 421.13K | 2.15K |
Turnover | 14.97B | 51.97M |
Average Price | 355.37 | 241.85 |
Value | 14.97B | 51.97M |
Indicative Equilibrium Price | 354 | 240 |
Indicative Equilibrium Volume | 734 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Janu Putra Sejahtera Tbk (the Entity) was established based on the Notarial Deed of Endang Sumarningsih, S.H., M.Kn., No. 7, dated December 27, 2007. The Entity started its commercial operations on 2007. The controlling party for the Company is H. Singgih Januratmoko.
Read more on AYAM →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →